Mayo Clinic is a member of the Children's Oncology Group (COG), the national cooperative group for clinical trials and basic science investigation of childhood cancers. Mayo participates actively in COG trials to provide state-of-the-art clinical trials to children with cancer.
The Division of Pediatric Hematology/Oncology at Mayo Clinic is a member of a consortium of cancer centers across the United States established by the National Cancer Institute (NCI) as Phase I investigational centers. These institutions study and develop cutting-edge technologies and protocols for the successful treatment of neuroblastoma and other childhood cancers. Mayo specialists have access to experimental agents and new, investigational drugs as soon as these treatments are available. Phase I trials are utilized for patients whose tumors have recurred after standard therapy has failed.
Clinical trials are research studies that test new ways to detect, prevent or treat disease. Mayo Clinic conducts more than 3,000 clinical trials and research studies each year and often coordinates national clinical trials with other medical centers.
Learn more about clinical trials and whether Mayo Clinic may be conducting a clinical trial related to your condition or procedure.